Last reviewed · How we verify

dexketoprofen trometamol + tramadol hydrochloride

Kavaklıdere Umut Hospital · FDA-approved active Small molecule

dexketoprofen trometamol + tramadol hydrochloride is a NSAID + opioid analgesic combination Small molecule drug developed by Kavaklıdere Umut Hospital. It is currently FDA-approved for Moderate to moderately severe acute pain.

This combination product uses dexketoprofen (a nonsteroidal anti-inflammatory drug) to reduce inflammation and pain, and tramadol (an opioid analgesic) to provide additional pain relief through multiple mechanisms.

This combination product uses dexketoprofen (a nonsteroidal anti-inflammatory drug) to reduce inflammation and pain, and tramadol (an opioid analgesic) to provide additional pain relief through multiple mechanisms. Used for Moderate to moderately severe acute pain.

At a glance

Generic namedexketoprofen trometamol + tramadol hydrochloride
SponsorKavaklıdere Umut Hospital
Drug classNSAID + opioid analgesic combination
TargetCOX-1/COX-2 (dexketoprofen); mu-opioid receptor, norepinephrine transporter, serotonin transporter (tramadol)
ModalitySmall molecule
Therapeutic areaPain Management
PhaseFDA-approved

Mechanism of action

Dexketoprofen trometamol is the active S-enantiomer of ketoprofen that inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin synthesis and thereby decreasing inflammation, pain, and fever. Tramadol hydrochloride is a synthetic opioid that acts as a mu-receptor agonist and also inhibits the reuptake of norepinephrine and serotonin, providing multimodal analgesia. Together, they provide synergistic pain relief for moderate to moderately severe acute pain.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about dexketoprofen trometamol + tramadol hydrochloride

What is dexketoprofen trometamol + tramadol hydrochloride?

dexketoprofen trometamol + tramadol hydrochloride is a NSAID + opioid analgesic combination drug developed by Kavaklıdere Umut Hospital, indicated for Moderate to moderately severe acute pain.

How does dexketoprofen trometamol + tramadol hydrochloride work?

This combination product uses dexketoprofen (a nonsteroidal anti-inflammatory drug) to reduce inflammation and pain, and tramadol (an opioid analgesic) to provide additional pain relief through multiple mechanisms.

What is dexketoprofen trometamol + tramadol hydrochloride used for?

dexketoprofen trometamol + tramadol hydrochloride is indicated for Moderate to moderately severe acute pain.

Who makes dexketoprofen trometamol + tramadol hydrochloride?

dexketoprofen trometamol + tramadol hydrochloride is developed and marketed by Kavaklıdere Umut Hospital (see full Kavaklıdere Umut Hospital pipeline at /company/kavakl-dere-umut-hospital).

What drug class is dexketoprofen trometamol + tramadol hydrochloride in?

dexketoprofen trometamol + tramadol hydrochloride belongs to the NSAID + opioid analgesic combination class. See all NSAID + opioid analgesic combination drugs at /class/nsaid-opioid-analgesic-combination.

What development phase is dexketoprofen trometamol + tramadol hydrochloride in?

dexketoprofen trometamol + tramadol hydrochloride is FDA-approved (marketed).

What are the side effects of dexketoprofen trometamol + tramadol hydrochloride?

Common side effects of dexketoprofen trometamol + tramadol hydrochloride include Nausea, Dizziness, Constipation, Gastrointestinal upset, Headache, Somnolence.

What does dexketoprofen trometamol + tramadol hydrochloride target?

dexketoprofen trometamol + tramadol hydrochloride targets COX-1/COX-2 (dexketoprofen); mu-opioid receptor, norepinephrine transporter, serotonin transporter (tramadol) and is a NSAID + opioid analgesic combination.

Related